Pfizer Inc

A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2

Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer.

Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2

A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer (NSCLC) Which Has Spread Out.

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)

Role of Immune System in Obesity-related Inflammation and Cardiometabolic Risk

A Study to Learn How the Study Medicine Called PF-08653944 is Taken up Into the Blood in Adults With Overweight or Obesity.

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

Acute Migraine Treatment in the ED With Gepants

FungiScope - A Global Emerging Fungal Infection Registry

ASCVD Management Using CCTA in Prostate Cancer Patients on ADT

A Study to Learn How the Body Processes the Study Medicine Called Vepdegestrant in People With Loss of Liver Function

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)

A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer

Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides

A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors